The NAPA Quality team then collaborated with the ABG QCDR, administered by Graphium Health, to submit this measure to CMS for inclusion in the 2025 Quality Payment Program (QPP) MIPS track as ABG 45: Aspiration Prevention in Patients with Gastric Distension. Rafael Cartagena , MD, NAPA CEO, emphasized NAPA leadership in advancing anesthesia safety
doi: 10.1111/obr.13929, 7 Bernosky-SmithK
I have not personally seen most of the other symptoms highlighted in the study in a consistent or clinically significant way
Use In Specific Populations 8.1 Pregnancy Risk Summary Published studies with use of insulin glargine products during pregnancy have not reported a clear association with insulin glargine products and adverse developmental outcomes (see Data)
Now, science has finally caught up
These injections work by helping regulate hunger signals, improve satiety, and reduce calorie intake